Curis skyrockets 448% after encouraging phase 1 data for leukemia treatment

Retrieved on: 2020-12-08 20:57:46

Tags for this article:

Click the tags to see associated articles and topics

Curis skyrockets 448% after encouraging phase 1 data for leukemia treatment. View article details on hiswai:

Excerpt

Small-cap <b>biotechnology</b> firm Curis surged as much as 448% on Tuesday after the company released encouraging phase I data for its leukemia ...

Article found on: www.businessinsider.com